Mutation analysis of protein tyrosine kinases identified some recurrent mutations in ERBB4 (19% of melanomas) and Fms related Tyrosine Kinase 1 (FLT1) and Protein Tyrosine Kinase 2 Beta (PTK2B) (10% of melanomas) [45]. Here, FLT1 is linked to melanoma.